XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.3
Licensed Rights and Other Intangible Assets (Tables)
 9 Months Ended
Sep. 30, 2024
Licensed Rights and Other Intangible Assets [Abstract]  
Schedule of License Rights and Other Intangible Assets, Net The following provides information about our license rights and other intangible assets, net as of September 30, 2024 and December 31, 2023 (in thousands):
   September 30, 2024   December 31, 2023 
   Gross
Carrying
Amount		   Accumulated
Amortization		   Net   Gross
Carrying
Amount		   Accumulated
Amortization		   Net 
Intangible assets subject to amortization:                              
Hormone therapy drug patents  $5,753   $1,957   $3,796   $6,818   $1,871   $4,947 
Hormone therapy drug patents applied and pending approval   323    
—
    323    842    
—
    842 
Intangible assets subject to amortization   6,076    1,957    4,119    7,660    1,871    5,789 
Intangible assets not subject to amortization:                              
Trademarks/trade name rights   309    
—
    309    309    
—
    309 
License rights and other intangible assets, net  $6,385   $1,957   $4,428   $7,969   $1,871   $6,098 
Schedule of Intangible Assets Subject to Amortization Our intangible assets subject to amortization are expected to be amortized as follows (in thousands):
Year ending December 31,    
2024  $97 
2025   384 
2026   384 
2027   384 
2028   384 
Thereafter   2,163 
Total  $3,796